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Abstract
NRLP1 (rs12150220, rs9889625, rs9900356, rs6502867, rs2670660) and NLRP3 (rs35829419, rs10754558) polymorphisms
have been analyzed in 69 subjects with documented asbestos exposure and death for malignant pleural mesothelioma
and 59 patients with documented asbestos exposure but death for other causes, all from a North East Italy. No
association was found between NLRP1 and NLRP3 polymorphisms and susceptibility to develop mesothelioma using
the general, dominant or recessive models. Also haplotype analysis did not reveal any significant association with
mesothelioma. Our findings, being controversial with respect to another study on Italian patients, do suggest the need
of further studies to unravel the contribution of NLRP1 and NLRP3 in susceptibility to mesothelioma.
Keywords: Mesothelioma, Inflammasome, NLRP1 and NLRP3 polymorphisms, Asbestos exposure, Haplotypes
Findings
The involvement of inflammasome in susceptibility to
develop malignant pleural mesothelioma (MPM), con-
sidering its capacity to sense asbestos fibres has been
already reported [1] and several papers have been pub-
lished so far on this topic [2–4].
Genetic susceptibility to mesothelioma has been widely
analyzed and some recent genome wide studies pointed
out several susceptibility genes (i.e. BAP1, NF2, CDKN2A,
CUL1, SLC7A14, THRB, CEBP350, ADAMTS2, ETV1,
PVT1 and MMP14), but genetic variants in inflamma-
some genes such as NLRP3 and NLRP1 have not been as-
sociated to mesothelioma [5–7]. However, Girardelli et al.
[8] reported an association of rs12150220 NLRP1 poly-
morphism with mesothelioma in Italian patients the pres-
ence of T allele conferred a major risk (OR 1.79) to
acquire the disease.
With the aim of replicating Girardelli et al. [8] results,
we analyzed NRLP1 and NLRP3 polymorphisms in sub-
jects exposed to asbestos from North East Italy.
We collected 128 subjects deceased during the period
1980–2000, of which 69 with documented asbestos ex-
posure and death for MPM (AEM) and 59 patients with
documented asbestos exposure but death for causes dif-
ferent from MPM and other asbestos related diseases
(AENM), used as controls. All subjects were character-
ized based on information available in medical records
and the MPM diagnosis was performed by histologic
examination. For the AENM group objective signs con-
firming asbestos exposure were the presence of hyaline
plaque at autopsy (≥2°) at pleural level, presence of as-
bestos bodies (AB) in routine lung sections and (for
most cases) counts of AB, expressed as number of AB
per gram of dry lung tissue, ≥10.000/g.
Genomic DNA of AEM and AENM was extracted from
formalin-fixed and paraffin-embedded archived autopsy
heart tissue slices (about 40–50 slices with a thickness of
5–7 μm were cut from the same paraffin block) using the
QIAsymphony DSP DNA mini kit (QIAGEN, Hilden,
Germany) and eluted in 50ul of TE buffer.
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Quantitative and qualitative evaluation of extracted
DNA was performed using NanoDrop ND-1000 (Termo
Scientific, Wilmington, USA); electrophoresis on agarose
gel allowed us to verify the degree of DNA degradation.
We genotyped two NLRP3 polymorphisms (rs35829419,
cSNP and rs10754558, Tag SNP) and five NLRP1 polymor-
phisms (rs12150220, cSNP; rs9889625, Tag SNP; rs9900
356, Tag SNP; rs6502867, Tag SNP; rs2670660, Tag
SNP) using the following Taqman genotyping assays:
NLRP3 C__25648615_10, C__26052028_10; NLRP1
C___1600653_10, C___1274455_10, C__29796119_10,
C__29222211_20 and C___1600689_10. Allelic specific
PCR reactions have been run on ABI 7500 real time in-
strument (Life Technologies, Foster City, CA). SDS soft-
ware (Life Technologies) allowed allelic discrimination
and genotyping.
Table 1 summarizes the distribution of NLRP1 and
NLRP3 polymorphisms genotype counts among the AEM
and AENM groups (a graphic representation is also pro-
vided as Additional file 1: Figure S1). All markers were in
Hardy-Weinberg Equilibrium (HWE) in both AEM and
AENM groups with the exception of NLRP1 rs9900356
SNP in AEM group and NLRP3 rs35829419, which was
not in HWE in AENM and AEM.
No association was found between NLRP1 and NLRP3
polymorphisms and susceptibility to develop mesotheli-
oma using the general, dominant or recessive models.
Moreover, we evaluated the formation of haplotypes in
NLRP1 and NLRP3 genes. We detected two blocks for
NLRP1: Haplo1 (rs9900356, rs6502867 and rs9889625;
D’ = 1) and Haplo2 (rs12150220 and rs2670660; D’ = 0.83).
The two NLRP3 SNPs also formed a haplotype (D’ = 1).
We estimated the haplotype frequencies of the NLRP1
and NLRP3 polymorphisms in AEM and AENM individ-
uals and no association with susceptibility to the disease
was found; haplotype distributions are in Additional file 2:
Table S1; Additional file 3: Figure S2, reports the haplo-
blocks found for NLRP1 and NRLP3 SNPs.
So the association (for both rs12150220 SNP and
rs12150220- rs2670660 haplotype) with susceptibility to
mesothelioma reported by Girardelli et al. [8] has not been
replicated in our study, also performed in Italian patients
and controls (our samples were from Monfalcone, an in-
dustrial area with endemic exposition to asbestos).
However, in the study of Girardelli et al. NLRP1 and
NRLP3 polymorphisms have been evaluated in patients
with mesothelioma and controls living in a geographic
area known to be at risk of asbestos exposure, while in
our study both mesothelioma patients and controls had
documented asbestos exposure (see Additional file 4:
Table S2 for details), so our genetic analysis has been
performed on more homogeneous cohorts.
Girardelli et al. [8] et al. hypothesized a role for NLRP1
inflammasome in the context of mesothelioma on the
basis of NLRP1 lung expression (alveolar macrophages
and epithelial cells), a location where this innate immune
protein could act as sensor of asbestos fibres. The authors
suggested a possible functional role for NLRP1 functional
SNP rs12150220, indicating the presence of the T allele as
able to imbalance NLRP1 production. Since no functional
data are already available in the literature for rs12150220
variation, we performed an in silico search with SIFT and
Polyphen softwares able to predict an eventual detrimental
effect of the SNP: both SIFT (0.16) and Polyphen (0.415)
predictive values indicate no damaging effect for NLRP1
rs12150220 SNP. Being aware of the limitations of in silico
Table 1 NLRP1 and NLRP3 polymorphisms genotype counts
among the AEM and AENM groups
NLRP1
SNP AEM (n = 69) AENM (n = 59) OR 95 % CI p-value
rs9900356
T/T 40 34 1.00 Ref
T/C 25 23 0.92 0.45 - 1.91 0.9781
C/C 4 2 1.70 0.29 - 9.86 0.8645
rs6502867
T/T 36 34 1.00 Ref
T/C 23 19 1.14 0.53 - 2.46 0.8835
C/C 10 6 1.57 0.52 - 4.80 0.6008
rs9889625
G/G 29 25 1.00 Ref
A/G 25 21 1.03 0.47 - 2.26 0.8911
A/A 15 13 0.99 0.40 - 2.48 0.8242
rs12150220
A/A 20 18 1.00 Ref
T/A 29 25 1.04 0.45 - 2.40 0.9118
T/T 20 16 1.13 0.45 - 2.81 0.9849
rs2670660
A/A 17 15 1.00 Ref
A/G 34 30 1.00 0.43 - 2.34 0.8283
G/G 18 14 1.13 0.42 - 3.04 1.0000
NLRP3
SNP AEM (n = 69) AENM (n = 59) OR 95 % CI
rs35829419
C/C 60 52 1.00 Ref
A/C 6 6 0.87 0.26 - 2.85 0.9452
A/A 3 1 2.60 0.26 - 25.76 0.7379
rs10754558
C/C 23 23 1.00 Ref
C/G 33 25 1.32 0.61 - 2.87 0.6152
G/G 13 11 1.18 0.44 - 3.18 0.9369
OR Odds Ratio, CI Confidence Interval, Ref reference genotype (the most
frequent)
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SNPs functional prediction, the hypothesized role of this
variation should be functionally verified.
In conclusion, our study, performed on patients and
controls with homogeneous asbestos exposure, does not
confirm the involvement of NLRP1 inflammasome in the
susceptibility to mesothelioma in Italian patients, pointing
out the necessity to analyze a wider number of individuals,
such as those used in the most recent genome wide stud-
ies, to deeper investigate the contribution of the inflam-
masome to the multifactorial mesothelioma.
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